The A1c-Cellular®, an HbA1c control with intact red blood cells from Streck, Omaha, Neb, is now assayed for Roche cobas® c 311.
A1c-Cellular tests the entire HbA1c procedure, including the lysing of the red blood cells.
This important step ensures the entire system–instrument and reagents–is working properly and providing accurate patient results. The control is easy to use; it does not require reconstitution, which reduces the potential for human error.
The control is appropriate for immunoassay and ionic exchange HPLC methodologies.
It is also assayed for the Abbott ARCHITECT® c Systems; Arkray Menarini ADAMS™ A1c HA-8160; Beckman Coulter® UniCel® DxC 600/800 Synchron®; Bio-Rad® D10/Variant II™/Variant II Turbo; Ortho-Clinical Diagnostics VITROS® 5, 1 FS/VITROS 5600; Roche cobas Integra®/cobas 6000; Siemens Healthcare Diagnostics Inc Dimension Series; and the Tosoh A1c 2.2 Plus/G7/G8.
Available in 2.0ml plastic screw-top, cap-pierceable vials, the control offers a closed-vial stability of 6 months and an open-vial stability of 30 days.
[Source: Streck]
 |
 |
 |
 |
CLP is the only magazine that focuses exclusively on products and technology for the clinical lab industry. Every month, CLP's editorial provides 45,000 pathologists, lab managers, administrators and technologists with comprehensive coverage of new products and technology.
RSS